TriNetX Announces the Appointment of Arnaub Chatterjee as Chief Product and Solutions Officer

Rhea-AI Summary

TriNetX, a global network for real-world research, has appointed Arnaub Chatterjee as Chief Product and Solutions Officer. Chatterjee previously served as Senior VP at Medidata AI and has a robust background in healthcare leadership, including roles at McKinsey & Company and Merck. His expertise in data science and clinical research is expected to enhance TriNetX's capabilities in generating regulatory-grade real-world evidence. Chatterjee holds degrees from Cornell University and the University of Michigan and is involved in academia as a faculty member at Harvard Medical School and Cornell. His leadership may accelerate the development of new therapies.

Positive

• Appointment of Arnaub Chatterjee expected to bolster leadership and innovation at TriNetX.
• Chatterjee's experience in data science aligns well with TriNetX's focus on real-world data solutions.

Negative

• None.

CAMBRIDGE, Mass., Feb. 14, 2023 /PRNewswire/ -- TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, today announced that Arnaub Chatterjee has joined the company as Chief Product and Solutions Officer.

"Arnaub is a proven leader and strategic advisor who has delivered novel software and data science solutions that have advanced clinical research and development and patient care," said Gadi Lachman, CEO and Founder of TriNetX.

Arnaub joins TriNetX from Medidata AI, the data sciences entity of Medidata Solutions, where he served as Senior Vice President. Prior to Medidata, he was a leader and strategic advisor within McKinsey & Company, Merck and the Obama Administration.   Arnaub holds graduate degrees in health administration (MHA) and public administration (MPA) from Cornell University and earned his undergraduate degree from the University of Michigan.

Arnaub is passionate about education and is a faculty member at Harvard Medical School in the Department of Healthcare Policy, as well as at Cornell University in the Department of Policy Analysis and Management. In addition, he has been engaged by the Carlyle Group as an advisor focusing on their life sciences and technology strategy. Arnaub has served as a board member and advisor for a number of additional organizations including the World Economic Forum's Council for Biotechnology and Biospring Partners, a life sciences growth equity firm. His work has been published in journals such as Harvard Business Review and Nature.

"I am thrilled to join TriNetX and to help fulfill the potential of real-world data to bring novel therapies to patients," said Arnaub Chatterjee. "The company has established itself as the trusted market leader for the secondary use of real-world data across all therapeutic areas, as well as for regulatory-grade real-world evidence generation, and for collaboration across its global community of investigators, healthcare organizations, and pharmaceutical companies."

About TriNetX, LLC
TriNetX is a global network of healthcare organizations and life sciences companies driving real-world research to accelerate the development of new therapies. Through its self-service, HIPAA, GDPR, and LGPD-compliant platform of federated EHR, datasets, and consulting partnerships, TriNetX puts the power of real-world data into the hands of its worldwide community to improve protocol design, streamline trial operations, refine safety signals, and enrich real-world evidence generation. For more information, visit TriNetX at www.trinetx.com or follow @TriNetX on Twitter.

Media Contact
TriNetX, LLC
Bill Stetson
(857) 285-6038
press@trinetx.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/trinetx-announces-the-appointment-of-arnaub-chatterjee-as-chief-product-and-solutions-officer-301746295.html

SOURCE TriNetX

FAQ

Who is Arnaub Chatterjee and what is his role at TriNetX?

Arnaub Chatterjee is the newly appointed Chief Product and Solutions Officer at TriNetX, bringing extensive experience in healthcare and data science.

What experience does Arnaub Chatterjee bring to TriNetX?

Chatterjee has held leadership positions at Medidata AI, McKinsey & Company, and Merck, specializing in clinical research and data science.

How might Arnaub Chatterjee's appointment impact TriNetX?

His leadership is anticipated to enhance TriNetX's capabilities in real-world data research and accelerate therapy development.

What is TriNetX's focus in the healthcare sector?

TriNetX focuses on leveraging real-world data to improve clinical research and accelerate the development of new therapies.